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Introduction
Idiopathic normal pressure hydrocephalus (iNPH) is a
treatable but underdiagnosed condition. The number of
diagnosed patients will probably increase in the future
which will increase costs and challenge allocation of
resources. Shunt surgery is successful in most patients
and we recently reported that 86% of operated patients
improved their health related quality of life (HRQOL),
almost to the same level as found in the normal popula-
tion. However, the cost-effectiveness of treatment for
iNPH has not been reported. The aim of this study was
to simulate the long-term effects and costs of shunt sur-
gery versus no treatment in iNPH in a Swedish setting.
Methods
The cost-utility analysis of shunt surgery was based on a
decision-analytic Markov model adapted to Swedish cir-
cumstances. The effectiveness measure was quality-
adjusted life years (QALYs) gained per patient. Costs
were derived from the European iNPH Multicenter Study
and data on costs of dementia disorders in Sweden
reported by the National Board of Health and Welfare.
Data from thirty-seven patients with iNPH (median age
70 years, range 50-89 years) evaluated before and six
months after surgery with the EQ-5D (EuroQol Group-5
Dimension health survey) was used to calculate quality
adjusted life years (QALYs). Figures of prevalence, nat-
ural course of iNPH and transition probabilities were
obtained from the literature. One-way sensitivity analysis
and probabilistic sensitivity analysis were carried out to
investigate the robustness of the model.
Results
The preliminary model showed that shunt surgery in iNPH
resulted in a gain of 3.03 life years and 3.12 QALYs along
with an incremental cost of approximately $48,021 or
£32,014. The incremental cost-effectiveness ratio (ICER)
was estimated to $15,550 or £10,000 per gained QALY.
Conclusions
From the preliminary result of the simulation model, it
can be concluded that shunt treatment in iNPH is cost-
effective. The estimated average ICER of £10,000 per
gained QALY is below the UK National Institute for
Health and Care Excellence (NICE) acceptance level of
£20,000 for cost-effective interventions.
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